127 related articles for article (PubMed ID: 38704065)
1. ICG-labeled PD-L1-antagonistic affibody dimer for tumor imaging and enhancement of tumor photothermal-immunotherapy.
Jia D; Zhao S; Liu H; Zhan X; Zhou Z; Lv M; Tang X; Guo W; Li H; Sun L; Zhong Y; Tian B; Yuan D; Tang X; Fan Q
Int J Biol Macromol; 2024 Jun; 269(Pt 2):132058. PubMed ID: 38704065
[TBL] [Abstract][Full Text] [Related]
2. In Vivo Evaluation and Dosimetry Estimate for a High Affinity Affibody PET Tracer Targeting PD-L1.
Rubins DJ; Meng X; McQuade P; Klimas M; Getty K; Lin SA; Connolly BM; O'Malley SS; Haley H; Purcell M; Gantert L; Holahan M; Lindgren J; Eklund P; Ekblad C; Frejd FY; Hostetler ED; González Trotter DE; Evelhoch JL
Mol Imaging Biol; 2021 Apr; 23(2):241-249. PubMed ID: 33098025
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional Nanoparticles-Mediated PTT/PDT Synergistic Immune Activation and Antitumor Activity Combined with Anti-PD-L1 Immunotherapy for Breast Cancer Treatment.
Kong C; Xu B; Qiu G; Wei M; Zhang M; Bao S; Tang J; Li L; Liu J
Int J Nanomedicine; 2022; 17():5391-5411. PubMed ID: 36419717
[TBL] [Abstract][Full Text] [Related]
4. GSH/pH dual response drug delivery system for photothermal enhanced gene-immunotherapy.
Ma T; Li W; Ye J; Huang C; Li Y; Qiu H; Yin S
Nanoscale; 2023 Nov; 15(42):16947-16958. PubMed ID: 37779508
[TBL] [Abstract][Full Text] [Related]
5. ICG-Dimeric Her2-Specific Affibody Conjugates for Tumor Imaging and Photothermal Therapy for Her2-Positive Tumors.
Jia D; Liu H; Zheng S; Yuan D; Sun R; Wang F; Li Y; Li H; Yuan F; Fan Q; Zhao Z
Mol Pharm; 2023 Jan; 20(1):427-437. PubMed ID: 36315025
[TBL] [Abstract][Full Text] [Related]
6. Her3-specific affibody mediated tumor targeting delivery of ICG enhanced the photothermal therapy against Her3-positive tumors.
Liu H; Jia D; Yuan F; Wang F; Wei D; Tang X; Tian B; Zheng S; Sun R; Shi J; Fan Q
Int J Pharm; 2022 Apr; 617():121609. PubMed ID: 35217073
[TBL] [Abstract][Full Text] [Related]
7. Second near-infrared photothermal-amplified immunotherapy using photoactivatable composite nanostimulators.
Sun H; Yu T; Li X; Lei Y; Li J; Wang X; Peng P; Ni D; Wang X; Luo Y
J Nanobiotechnology; 2021 Dec; 19(1):433. PubMed ID: 34930269
[TBL] [Abstract][Full Text] [Related]
8. Selectively down-regulated PD-L1 by albumin-phenformin nanoparticles mediated mitochondrial dysfunction to stimulate tumor-specific immunological response for enhanced mild-temperature photothermal efficacy.
Zhou Z; Jiang N; Chen J; Zheng C; Guo Y; Ye R; Qi R; Shen J
J Nanobiotechnology; 2021 Nov; 19(1):375. PubMed ID: 34794446
[TBL] [Abstract][Full Text] [Related]
9. In Vivo Imaging of the Programmed Death Ligand 1 by
González Trotter DE; Meng X; McQuade P; Rubins D; Klimas M; Zeng Z; Connolly BM; Miller PJ; O'Malley SS; Lin SA; Getty KL; Fayadat-Dilman L; Liang L; Wahlberg E; Widmark O; Ekblad C; Frejd FY; Hostetler ED; Evelhoch JL
J Nucl Med; 2017 Nov; 58(11):1852-1857. PubMed ID: 28588151
[TBL] [Abstract][Full Text] [Related]
10. Development of novel peptide-based radiotracers for detecting PD-L1 expression and guiding cancer immunotherapy.
Zhu S; Liang B; Zhou Y; Chen Y; Fu J; Qiu L; Lin J
Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):625-640. PubMed ID: 37878029
[TBL] [Abstract][Full Text] [Related]
11. Precision USPIO-PEG-SLe
Li T; Guo L; Li J; Mu X; Liu L; Song S; Luo N; Zhang Q; Zheng B; Jin G
Int J Nanomedicine; 2024; 19():1249-1272. PubMed ID: 38348177
[TBL] [Abstract][Full Text] [Related]
12. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
[TBL] [Abstract][Full Text] [Related]
13. A Smart Multifunctional Nanoparticle for Enhanced Near-Infrared Image-Guided Photothermal Therapy Against Gastric Cancer.
Shao J; Liang R; Ding D; Zheng X; Zhu X; Hu S; Wei H; Wei B
Int J Nanomedicine; 2021; 16():2897-2915. PubMed ID: 33907399
[TBL] [Abstract][Full Text] [Related]
14. Enhancing Tumor Immunotherapy by Multivalent Anti-PD-L1 Nanobody Assembled via Ferritin Nanocage.
Liu M; Jin D; Yu W; Yu J; Cao K; Cheng J; Zheng X; Wang A; Liu Y
Adv Sci (Weinh); 2024 May; 11(20):e2308248. PubMed ID: 38491904
[TBL] [Abstract][Full Text] [Related]
15. Synergistic interventional photothermal therapy and immunotherapy using an iron oxide nanoplatform for the treatment of pancreatic cancer.
Wang M; Li Y; Wang M; Liu K; Hoover AR; Li M; Towner RA; Mukherjee P; Zhou F; Qu J; Chen WR
Acta Biomater; 2022 Jan; 138():453-462. PubMed ID: 34757232
[TBL] [Abstract][Full Text] [Related]
16. Rationally designed peptide-conjugated gold/platinum nanosystem with active tumor-targeting for enhancing tumor photothermal-immunotherapy.
Yang Q; Peng J; Shi K; Xiao Y; Liu Q; Han R; Wei X; Qian Z
J Control Release; 2019 Aug; 308():29-43. PubMed ID: 31252039
[TBL] [Abstract][Full Text] [Related]
17. Ultra-thin layered double hydroxide-mediated photothermal therapy combine with asynchronous blockade of PD-L1 and NR2F6 inhibit hepatocellular carcinoma.
Lu YF; Zhou JP; Zhou QM; Yang XY; Wang XJ; Yu JN; Zhang JG; Du YZ; Yu RS
J Nanobiotechnology; 2022 Jul; 20(1):351. PubMed ID: 35907841
[TBL] [Abstract][Full Text] [Related]
18. Potentiating dual-directional immunometabolic regulation with nanomedicine to enhance anti-tumor immunotherapy following incomplete photothermal ablation.
Jiang Q; Qiao B; Zheng J; Song W; Zhang N; Xu J; Liu J; Zhong Y; Zhang Q; Liu W; You L; Wu N; Liu Y; Li P; Ran H; Wang Z; Guo D
J Nanobiotechnology; 2024 Jun; 22(1):364. PubMed ID: 38915007
[TBL] [Abstract][Full Text] [Related]
19. Metal-organic framework-mediated multifunctional nanoparticles for combined chemo-photothermal therapy and enhanced immunotherapy against colorectal cancer.
Liu H; Xu C; Meng M; Li S; Sheng S; Zhang S; Ni W; Tian H; Wang Q
Acta Biomater; 2022 May; 144():132-141. PubMed ID: 35307591
[TBL] [Abstract][Full Text] [Related]
20. Biomimetic black phosphorus quantum dots-based photothermal therapy combined with anti-PD-L1 treatment inhibits recurrence and metastasis in triple-negative breast cancer.
Zhao P; Xu Y; Ji W; Zhou S; Li L; Qiu L; Qian Z; Wang X; Zhang H
J Nanobiotechnology; 2021 Jun; 19(1):181. PubMed ID: 34120612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]